secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001104659-26-025331
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics authorizes $2B buyback, enters $1.5B accelerated share repurchase with Citi
--------------------------------------------------------------------------------

- Board approves up to $2B stock repurchase program through March 9, 2027.
- ASR agreements with Citibank total $1.5B: $750M uncollared and $750M collared.
- Initial delivery of ~992,120 shares (uncollared, ~70%) and ~708,657 shares (collared, ~50%) on March 11, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926025331/0001104659-26-025331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926025331/tm268321d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-025331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer